These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4728918)

  • 1. Ataractic drugs versus ECT in schizophrenia.
    Spensley J
    Am J Psychiatry; 1973 Oct; 130(10):1162-3. PubMed ID: 4728918
    [No Abstract]   [Full Text] [Related]  

  • 2. [A therapeutic pathomorphosis of schizophrenia proceeding with paranoid disorders].
    Ozola MIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(4):600-5. PubMed ID: 5497116
    [No Abstract]   [Full Text] [Related]  

  • 3. ECT/chlorpromazine combination versus chlorpromazine alone in acutely schizophrenic patients.
    Janakiramaiah N; Channabasavanna SM; Murthy NS
    Acta Psychiatr Scand; 1982 Dec; 66(6):464-70. PubMed ID: 7180565
    [No Abstract]   [Full Text] [Related]  

  • 4. [The properdin system in patients with schizophrenia during the process of active therapy].
    Kaz'mina SA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(1):101-5. PubMed ID: 4147791
    [No Abstract]   [Full Text] [Related]  

  • 5. A double blind comparison of thiothixene and a trifluoperazine/chlorpromazine composite in the treatment of chronic schizophrenia.
    Knight RG; Harrison A
    N Z Med J; 1979 Apr; 89(634):302-4. PubMed ID: 377155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptic therapy for chronic schizophrenia.
    Ayd FJ
    Dis Nerv Syst; 1972 Jan; 33(1):35-9. PubMed ID: 5059687
    [No Abstract]   [Full Text] [Related]  

  • 7. A double blind controlled study of ECT vs chlorpromazine in schizophrenia.
    Bagadia VN; Abhyankar RR; Doshi J; Pradhan PV; Shah LP
    J Assoc Physicians India; 1983 Oct; 31(10):637-40. PubMed ID: 6671932
    [No Abstract]   [Full Text] [Related]  

  • 8. [Dynamics of integral parameters of the background EEG during treatment with neuroleptics].
    Bochkarev VK; Paniushkina SV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(2):258-64. PubMed ID: 6122319
    [No Abstract]   [Full Text] [Related]  

  • 9. Prolixin enanthate and thorazine-stelazine regimens in the treatment of schizophrenic patients. An experimental evaluation.
    DeWolfe AS; Barrell RP; London L; Spaner FE
    Psychosomatics; 1971; 12(3):186-90. PubMed ID: 4950862
    [No Abstract]   [Full Text] [Related]  

  • 10. Are antipsychotic drugs interchangeable?
    Gardos G
    J Nerv Ment Dis; 1974 Nov; 159(5):343-8. PubMed ID: 4612111
    [No Abstract]   [Full Text] [Related]  

  • 11. Intermittent pharmacotherapy in chronic schizophrenia.
    Prien RF; Gillis RD; Caffey EM
    Hosp Community Psychiatry; 1973 May; 24(5):317-22. PubMed ID: 4574574
    [No Abstract]   [Full Text] [Related]  

  • 12. Voltage laterality in the EEG of psychiatric patients.
    Serafetinides EA
    Dis Nerv Syst; 1973 Mar; 34(3):190-1. PubMed ID: 4715636
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the problem of the general and elective action of psycholeptics in the therapy of schizophrenia].
    Smulevich AB; Golovan' LI; Sokolova ED; Tsutsul'kovskaia MIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(2):246-50. PubMed ID: 5655743
    [No Abstract]   [Full Text] [Related]  

  • 14. Single daily doses of neuroleptic drugs.
    Brophy JJ
    Dis Nerv Syst; 1969 Feb; 30(2):120-3. PubMed ID: 5774571
    [No Abstract]   [Full Text] [Related]  

  • 15. High doses of chlorpromazine and trifluoperazine in the treatment of patients suffering from schizophrenia.
    Bagadia VN; Shastri PC; Dave KP; Shah LP
    J Postgrad Med; 1971 Jan; 17(1):2-9. PubMed ID: 5553769
    [No Abstract]   [Full Text] [Related]  

  • 16. Dopamine antagonism by thioridazine in schizophrenia.
    Meltzer HY; Sachar EJ; Frantz AG
    Biol Psychiatry; 1975 Feb; 10(1):53-7. PubMed ID: 1120175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive indices for chlorpromazine therapy in schizophrenics.
    Dixon PA; Oforah E; Makanjuola R
    Br J Clin Pharmacol; 1982 Aug; 14(2):273-7. PubMed ID: 7104178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroleptic-induced reductions in serum dopamine-beta-hydroxylase in schizophrenia.
    Goodnick PJ; Tong C; Duncavage MB; Meltzer HY
    Biol Psychiatry; 1983 Dec; 18(12):1485-8. PubMed ID: 6140962
    [No Abstract]   [Full Text] [Related]  

  • 19. [Morphologic anomalies of lymphocytes in schizophrenic patients in relation to various therapeutic methods].
    Belloni F
    Acta Neurol (Napoli); 1967; 22(5):689-700. PubMed ID: 5608897
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative studies of the effects of perazine, fluphenazine, trifluoperazine, chlorpromazine and haloperidol on primary and deficit symptoms of paranoid schizophrenia].
    Termińska K; Mrowiec W
    Psychiatr Pol; 1989; 23(1):24-30. PubMed ID: 2573098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.